Stivarga final NICE recommendation for hepatocellular carcinoma

9th January 2019 Uncategorised 0

Bayer’s Stivarga has received a final green light from the National Institute for Health and Care Excellence (NICE) for use by the NHS to treat advanced liver cancer.

More: Stivarga final NICE recommendation for hepatocellular carcinoma
Source: News